Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
Assay Drug Dev Technol ; 15(3): 89-105, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28346800

ABSTRACT

Discovering of new and effective antibiotics is a major issue facing scientists today. Luckily, the development of computer science offers new methods to overcome this issue. In this study, a set of computer software was used to predict the antibacterial activity of nonantibiotic Food and Drug Administration (FDA)-approved drugs, and to explain their action by possible binding to well-known bacterial protein targets, along with testing their antibacterial activity against Gram-positive and Gram-negative bacteria. A three-dimensional virtual screening method that relies on chemical and shape similarity was applied using rapid overlay of chemical structures (ROCS) software to select candidate compounds from the FDA-approved drugs database that share similarity with 17 known antibiotics. Then, to check their antibacterial activity, disk diffusion test was applied on Staphylococcus aureus and Escherichia coli. Finally, a protein docking method was applied using HYBRID software to predict the binding of the active candidate to the target receptor of its similar antibiotic. Of the 1,991 drugs that were screened, 34 had been selected and among them 10 drugs showed antibacterial activity, whereby drotaverine and metoclopramide activities were without precedent reports. Furthermore, the docking process predicted that diclofenac, drotaverine, (S)-flurbiprofen, (S)-ibuprofen, and indomethacin could bind to the protein target of their similar antibiotics. Nevertheless, their antibacterial activities are weak compared with those of their similar antibiotics, which can be potentiated further by performing chemical modifications on their structure.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Physiological Phenomena/drug effects , Biological Assay/methods , Drug Evaluation, Preclinical/methods , Microbial Sensitivity Tests/methods , Protein Interaction Mapping/methods , Anti-Bacterial Agents/chemistry , Computational Biology , Drug Discovery , Gram-Negative Bacteria/drug effects , Molecular Docking Simulation/methods
3.
Am J Pathol ; 168(5): 1435-42, 2006 May.
Article in English | MEDLINE | ID: mdl-16651611

ABSTRACT

Fatty acid ethyl esters (FAEEs), nonoxidative metabolites of ethanol, have been implicated in ethanol-induced heart injury. To assess the in vivo production of FAEEs by myocardial tissue, we used a modified ethanol ablation procedure in pigs. A controlled 60-minute ethanol infusion was administered into the distal left anterior descending coronary artery in seven swine; serial blood sampling of the coronary sinus and peripheral vein before, during, and after infusion allowed measurement of FAEE production and ethanol levels in the coronary sinus and the peripheral circulation. In a single animal, FAEEs were also quantified from nine different sites within the myocardium. FAEEs were produced by the heart within 5 minutes of exposure to ethanol, with very high concentrations of FAEEs detected in coronary sinus blood. Significant variability in amounts of FAEEs was detected in different regions of the heart tissue. A strong correlation was found between coronary sinus FAEEs and ethanol concentration (r = 0.9241, P < 0.00001). FAEE production by the heart after delivery of ethanol into the left anterior descending coronary artery was rapid, reaching levels in the coronary sinus blood 4 to 10 times greater than that found in peripheral blood after ethanol intake. These data demonstrate that FAEEs may be mediators of ethanol-induced cardiotoxicity.


Subject(s)
Coronary Vessels/physiology , Ethanol/pharmacokinetics , Fatty Acids/metabolism , Myocardium/metabolism , Animals , Catheter Ablation , Echocardiography , Esterification , Ethanol/blood , Swine
4.
Lipids ; 38(10): 1051-5, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14669970

ABSTRACT

FA ethyl esters (FAEE) are nonoxidative metabolites of ethanol produced by the esterification of FA and ethanol. FAEE have been implicated as mediators of ethanol-induced organ damage in vivo and in vitro, and are markers of ethanol intake. Upon ethanol intake, FAEE are synthesized in the liver and pancreas in significant quantities. There is limited information on the stimulation of FAEE synthesis upon addition of exogenous FA in vitro. HepG2 cells were incubated with ethanol alone, ethanol with 25 microM linoleate, and ethanol with 25 microM stearate. The amount of FAEE in human hepatoblastoma (HepG2) cells was determined 1-3 h after ethanol and FA addition. Stearate increased the FAEE concentration in HepG2 cells when incubated with the cells for 1 h, whereas linoleate did not increase the cellular FAEE concentration at any time. Ethyl palmitate, ethyl stearate, and ethyl oleate were the predominant FAEE species identified in all cases, independent of the specific supplemental FA added to the medium.


Subject(s)
Ethanol/pharmacology , Fatty Acids/biosynthesis , Stearic Acids/pharmacology , Carcinoma, Hepatocellular/metabolism , Cell Line, Tumor , Esterification , Esters , Humans , Liver Neoplasms/metabolism
5.
Article in English | MEDLINE | ID: mdl-12324241

ABSTRACT

Fatty acid ethyl esters (FAEE), esterification products of fatty acids and ethanol, have been shown to be mediators of ethanol-induced cell injury and their presence in the blood and tissues is a marker of ethanol intake. Recently, it has been shown that FAEE are produced within seconds of infusion of ethanol into the heart, when using a protocol similar to that used for myocardial ablation. This raises the possibility that the mechanism for the death of myocytes in cardiac ablation involves the generation of toxic FAEE. It has also been recently demonstrated that chronic alcoholics have a high concentration of a specific FAEE species--ethyl oleate. The use of the serum ethyl oleate concentration may be helpful in differentiating binge drinkers from chronic alcoholics.


Subject(s)
Esters/metabolism , Fatty Acids/metabolism , Alcoholism/diagnosis , Biomarkers/analysis , Biomarkers/blood , Esterification , Esters/blood , Esters/isolation & purification , Ethanol/pharmacology , Fatty Acids/blood , Fatty Acids/isolation & purification , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...